- Investing Ideas
- /
- U.S. Top Growth Stocks
U.S. Top Growth Stocks
Results
108
108 companies
Grace Therapeutics
Market Cap: US$42.3m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$3.20
7D
5.6%
1Y
32.8%
Arcutis Biotherapeutics
Market Cap: US$2.1b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$17.15
7D
10.5%
1Y
59.2%
ATRenew
Market Cap: US$973.6m
Operates pre-owned consumer electronics transactions and services platform in the People’s Republic of China.
RERE
US$4.36
7D
-7.6%
1Y
82.4%
CorMedix
Market Cap: US$925.6m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$12.40
7D
-16.4%
1Y
121.4%
HubSpot
Market Cap: US$25.7b
Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.
HUBS
US$487.53
7D
0.9%
1Y
-1.4%
Byrna Technologies
Market Cap: US$445.4m
A less-lethal self-defense technology company, develops, manufactures, and sells less-lethal personal security solutions in the United States, South Africa, Europe, South America, Asia, and Canada.
BYRN
US$19.62
7D
-3.8%
1Y
30.9%
Atlassian
Market Cap: US$45.2b
Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.
TEAM
US$172.43
7D
-3.0%
1Y
6.0%
Sezzle
Market Cap: US$2.9b
Operates as a technology-enabled payments company primarily in the United States and Canada.
SEZL
US$85.85
7D
-9.2%
1Y
306.6%
Elastic
Market Cap: US$9.2b
A search artificial intelligence (AI) company, provides software platforms to run in hybrid, public or private clouds, and multi-cloud environments in the United States and internationally.
ESTC
US$86.71
7D
1.9%
1Y
22.0%
AC Immune
Market Cap: US$225.6m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$2.28
7D
11.8%
1Y
-25.2%
Simmons First National
Market Cap: US$3.0b
Operates as the bank holding company for Simmons Bank that provides banking and other financial products and services to individuals and businesses.
SFNC
US$20.88
7D
0.5%
1Y
1.7%
First Financial Bancorp
Market Cap: US$2.6b
Operates as the bank holding company for First Financial Bank that provides commercial banking and related services to individuals and businesses in Ohio, Indiana, Kentucky, and Illinois.
FFBC
US$26.38
7D
-0.4%
1Y
4.5%
First Internet Bancorp
Market Cap: US$217.0m
Operates as the bank holding company for First Internet Bank of Indiana that provides various commercial, small business, consumer, and municipal banking products and services to individuals and commercial customers in the United States.
INBK
US$24.43
7D
-2.7%
1Y
-27.7%
TWFG
Market Cap: US$1.5b
Operates an independent distribution platform for personal and commercial insurance products in the United States.
TWFG
US$25.84
7D
-2.3%
1Y
-13.0%
WesBanco
Market Cap: US$3.2b
Operates as the bank holding company for WesBanco Bank, Inc.
WSBC
US$32.28
7D
-1.6%
1Y
4.7%
Hudson Global
Market Cap: US$33.0m
Star Equity Holdings, Inc. provides talent solutions for mid-to-large-cap multinational companies and government agencies under the Hudson RPO brand in the Americas, the Asia Pacific, and Europe.
STRR
US$9.44
7D
0.3%
1Y
-40.9%
Ategrity Specialty Insurance Company Holdings
Market Cap: US$1.0b
Through its subsidiaries, provides excess and surplus lines insurance and reinsurance products to small and medium-sized businesses in the United States.
ASIC
US$21.30
7D
-5.9%
1Y
n/a
Zeta Global Holdings
Market Cap: US$4.4b
Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.
ZETA
US$18.90
7D
-3.8%
1Y
-24.6%
DexCom
Market Cap: US$31.6b
A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DXCM
US$80.51
7D
6.9%
1Y
15.5%
SIGA Technologies
Market Cap: US$602.9m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$8.42
7D
0.4%
1Y
5.6%
Capital One Financial
Market Cap: US$141.7b
Operates as the financial services holding company for the Capital One, National Association, which engages in the provision of various financial products and services in the United States, Canada, and the United Kingdom.
COF
US$221.53
7D
-2.5%
1Y
55.4%
Invivyd
Market Cap: US$222.2m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$1.14
7D
17.2%
1Y
26.5%
Vertex
Market Cap: US$3.8b
Provides enterprise tax technology solutions for retail trade, wholesale trade, and manufacturing industries in the United States and internationally.
VERX
US$24.04
7D
-6.9%
1Y
-31.8%
Equity Bancshares
Market Cap: US$815.4m
Operates as the bank holding company for Equity Bank that provides a range of banking, mortgage banking, and financial services to individual and corporate customers.
EQBK
US$42.20
7D
4.1%
1Y
9.5%
Dime Community Bancshares
Market Cap: US$1.3b
Operates as the holding company for Dime Community Bank that engages in the provision of various commercial banking and financial services.
DCOM
US$30.63
7D
-0.4%
1Y
23.7%
FinWise Bancorp
Market Cap: US$261.6m
Operates as the bank holding company for FinWise Bank that provides various banking products and services to individual and corporate customers in Utah.
FINW
US$19.35
7D
0.1%
1Y
40.2%
Neuphoria Therapeutics
Market Cap: US$22.4m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$11.89
7D
4.9%
1Y
n/a
Hope Bancorp
Market Cap: US$1.4b
Operates as the bank holding company for Bank of Hope that provides retail and commercial banking services for businesses and individuals in the United States.
HOPE
US$11.12
7D
-0.09%
1Y
-8.3%
Gulfport Energy
Market Cap: US$3.1b
Engages in the acquisition, exploration, and production of natural gas, crude oil, and natural gas liquids in the United States.
GPOR
US$175.14
7D
0.6%
1Y
26.8%
Pinnacle Financial Partners
Market Cap: US$7.5b
Operates as the bank holding company for Pinnacle Bank that provides various banking products and services to individuals, businesses, and professional entities in the United States.
PNFP
US$97.37
7D
0.2%
1Y
4.2%
Ardelyx
Market Cap: US$1.6b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.52
7D
2.5%
1Y
16.4%
MINISO Group Holding
Market Cap: US$7.5b
An investment holding company, engages in the retail and wholesale of design-led lifestyle and pop toy products in China, the rest of Asia, the Americas, Europe, Indonesia, and internationally.
MNSO
US$24.52
7D
-1.3%
1Y
48.0%
Harmony Biosciences Holdings
Market Cap: US$2.1b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$35.99
7D
-2.4%
1Y
1.1%
Super Micro Computer
Market Cap: US$24.0b
Develops and sells server and storage solutions based on modular and open-standard architecture in the United States, Asia, Europe, and internationally.
SMCI
US$40.41
7D
-2.7%
1Y
-1.4%
LexinFintech Holdings
Market Cap: US$1.0b
Offers online direct sales and online consumer finance services in the People’s Republic of China.
LX
US$6.09
7D
-3.6%
1Y
256.1%
Iovance Biotherapeutics
Market Cap: US$796.1m
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.
IOVA
US$2.49
7D
11.7%
1Y
-75.1%